Home / Accelagen Staff Announcement: Suzanne Leong
Accelagen Staff Announcement: Suzanne Leong
Accelagen Staff Announcement: Suzanne Leong

We are excited to formally welcome another highly experienced team member to Accelagen’s fast-growing Australian team, Suzanne Leong.
Joining the Accelagen team is Suzanne Leong, the company’s new Senior Clinical Data Manager, bringing with her over 20 years’ experience across Clinical Research Organisations (CROs), Pharmaceutical and Public Health industries.
With a Bachelor of Science in Microbiology and Immunology, as well as a Master of Technology Management, both from University of New South Wales (UNSW), Suzanne has a long track record of developing clinical trial databases and maintaining high quality clinical data.
She is both passionate about and proficient at bringing a high level of attention to detail to helping solve the kind of real-world, complex and nuanced research questions that we pride ourselves on at Accelagen.
Her role will give her the opportunity to use the wide range of knowledge and expertise she has gathered over two decades across various therapeutic areas, including Oncology, Infectious Diseases, Dermatology, Cardiology, and Endocrinology, and she will help us provide world-class expertise in clinical research services and data management.
A warm Accelagen welcome to Suzanne.
You might also like...
Meet Madeleine Reynard: The Organisational Force behind Accelagen
Find out what Accelagen’s EA and Office Manager, Madeleine Reynard, loves about her role keeping our fast-growing team connected and organised.
Read MoreDelivering a Data-Driven Future at Accelagen: Meet Janus and Jessie
Spotlighting our Data Management team—meet Janus Rowlan D. Relos and Jessie Lourdesamy, as they drive innovation and excellence in clinical data solutions.
Read MoreWhy Regulatory Affairs is the Backbone of Accelagen’s Expertise: Introducing Our Newest Regulatory Affairs Officers, Adriana Paola Camargo
As we expand our Regulatory Affairs team, learn how Accelagen is enhancing expertise in regulatory strategy, market authorisation, and patient impact.
Read More